NCT04388189View on ClinicalTrials.gov

Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion

PHASE4WithdrawnINTERVENTIONAL

0

Timeline

Start Date

October 15, 2020

Primary Completion Date

May 30, 2023

Study Completion Date

May 30, 2023

Conditions

Major Depressive Disorder

Interventions

DRUG

Duloxetine

FDA approved antidepressant

DRUG

Bupropion

FDA approved antidepressant

Sponsors

Lead Sponsor

Alto Neuroscience

All Listed Sponsors

lead

Alto Neuroscience

INDUSTRY